Immunohistological studies on clinically silent pituitary adenomas

1990 ◽  
Vol 1 (1) ◽  
pp. 37-44 ◽  
Author(s):  
Wolfgang Saeger ◽  
H. Günzl ◽  
Michaela Meyer ◽  
Cornelia Schulze ◽  
Dieter K. Lüdecke
2018 ◽  
Vol 104 (7) ◽  
pp. 2473-2489 ◽  
Author(s):  
Juliana Drummond ◽  
Federico Roncaroli ◽  
Ashley B Grossman ◽  
Márta Korbonits

Pituitary ◽  
2008 ◽  
Vol 12 (1) ◽  
pp. 80-86 ◽  
Author(s):  
Tania Daems ◽  
Johan Verhelst ◽  
Alex Michotte ◽  
Pascale Abrams ◽  
Dirk De Ridder ◽  
...  

2006 ◽  
Vol 111 (3) ◽  
pp. 264-271 ◽  
Author(s):  
Rolf Buslei ◽  
Jürgen Kreutzer ◽  
Bernd Hofmann ◽  
Verena Schmidt ◽  
Florian Siebzehnrübl ◽  
...  

1988 ◽  
Vol 118 (4) ◽  
pp. 533-537 ◽  
Author(s):  
H. M. Heshmati ◽  
G. Turpin ◽  
M. Kujas ◽  
X. Lam ◽  
R. Van Effenterre ◽  
...  

Abstract. An immunocytochemical study was performed by the indirect peroxidase method on the pituitary tumour of 37 patients with clinical and biological signs of silent adenoma. Antisera were used against human PRL, human GH, ACTH1-24, human ACTH17-39, α-melanocyte stimulating hormone (α-MSH), human β-endorphin, α-subunit of hCG (hCG-α), and β-subunits of human LH(LH-β), human FSH (FSH-β) and human TSH (TSH-β). Immunostaining in at least 5% of the tumour cell population, with one or more antisera, was present in 13 cases; hCG-α immunostaining was the one most frequently observed. Combined immunostaining was found in 7 cases. Exclusive immunostaining was present in 6 cases: 4 with hCG-α, 1 with ACTH1-24 and 1 with TSH-β It is concluded that a significant number of silent pituitary adenomas show a certain secretory pattern of pituitary hormones or subunits of glycoprotein hormones as revealed by the immunocytochemistry.


Author(s):  
Gamze Akkus ◽  
Barış Karagun ◽  
Nuri Eralp Çetinalp ◽  
Arbil Açıkalın ◽  
Mehtap Evran ◽  
...  

Background: Silent pituitary adenomas are clinically found to be non-functional (i.e., without clinically evident pituitary hormone production). Introduction: The aim of this study was to investigate subjects with silent pituitary adenomas for possible variations in their clinical status. Methods: A total of 102 patients who had undergone surgery for pituitary adenoma and had been diagnosed with silent pituitary adenoma was included in the study. The patients’ preoperative and postoperative hormonal parameters and magnetic resonance imaging (MRI) features were collected, and pathological specimens were re-evaluated. Results: Immunohistochemistry results of the 102 patients were as follows: hormone-negative adenomas (n=35) 35.5%; FSH+LH-positivity (n=32) 31.3%; ACTH-positivity (n=11) 10.7%; α-subunit-positivity (n= 9) 8.8%; prolactin-positivity (n=8) 7.8%; GH-positivity (n=6) 5.4%; and plurihormonal adenoma (n=1). The mean sizes of SGA, SGHA, and SCA were 28.0±12.7, 30.0±16.0, and 27.7±8.9mm (p>0.05), respectively. With the exception of silent gonadotroph adenomas (SGAs), female gender dominance was shown in patients with silent growth hormone adenoma (SGHA) and silent corticotroph adenoma (SCA). Although no clinical relevance was observed in relation to hormonal excess, preoperative GH (4.21±4.6,vs 0.27±0.36 p=0.00) was slightly more elevated in SGHA than in GH-negative adenomas. Additionally, preoperative basal ACTH values (47.3±28.7 vs 23.9±14.4, p=0.003) were also higher in SCA compared to the other types. Our findings revealed SCAs to be more aggressive behaviour than SGHAs and SGAs due to invasiveness in radiological imaging, their elevated re-operation and postoperative ACTH values. Conclusion: Silent pituitary adenomas represent a challenging diagnostic tumour group. Careful initial evaluation of patients with pituitary adenomas should consider any mild signs and symptoms of functionality, particularly in cases of GH- and ACTH-secreting adenomas.


2015 ◽  
Vol 44 (1) ◽  
pp. 79-87 ◽  
Author(s):  
Sarah E. Mayson ◽  
Peter J. Snyder

Author(s):  
Aksu Özge Baș ◽  
Özgür Demir ◽  
Canpolat Asena Gökçay ◽  
Demet Çorapçıoğlu

Author(s):  
D. J. McComb ◽  
J. Beri ◽  
F. Zak ◽  
K. Kovacs

Investigation of the spontaneous pituitary adenomas in rat have been limited mainly to light microscopic study. Furth et al. (1973) described them as chromophobic, secreting prolactin. Kovacs et al. (1977) in an ul trastructural investigation of adenomas of old female Long-Evans rats, found that they were composed of prolactin cells. Berkvens et al. (1980) using immunocytochemistry at the light microscopic level, demonstrated that some spontaneous tumors of old Wistar rats could contain GH, TSH or ACTH as well as PRL.


Sign in / Sign up

Export Citation Format

Share Document